Compare SRFM & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRFM | BHST |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | Canada |
| Employees | N/A | 87 |
| Industry | Transportation Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.3M | 104.2M |
| IPO Year | 2023 | N/A |
| Metric | SRFM | BHST |
|---|---|---|
| Price | $1.32 | $4.33 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $3.25 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 2.0M | 16.2K |
| Earning Date | 03-12-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.69 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $106,557,000.00 | N/A |
| Revenue This Year | $10.33 | $116.40 |
| Revenue Next Year | $66.62 | $55.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.34 | $4.10 |
| 52 Week High | $9.35 | $12.80 |
| Indicator | SRFM | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 24.15 | 44.48 |
| Support Level | N/A | $4.19 |
| Resistance Level | $2.20 | $5.02 |
| Average True Range (ATR) | 0.15 | 0.24 |
| MACD | -0.05 | 0.03 |
| Stochastic Oscillator | 1.15 | 31.08 |
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.